Pakistan Pharma Guide Apr 2026

Over 700 registered pharma companies operate in Pakistan. However, nearly 80% of the market share is held by the top 30 players. The rest are "garage start-ups"—small units often operating on thin margins, producing generics in non-compliant environments. Chapter 2: The Price War (Drug Pricing & Regulation) If there is a single sword hanging over every CEO’s head, it is the Drug Pricing Policy . The Drug Regulatory Authority of Pakistan (DRAP) is the gatekeeper.

Always consult a registered medical practitioner. The author does not endorse specific brands mentioned for commercial purposes. | Rank | City | Specialization | | :--- | :--- | :--- | | 1 | Karachi (SITE/Korangi) | API & Finished Goods (70% of national production) | | 2 | Lahore (Sundar/Raiwind) | Formulations & Syrups | | 3 | Islamabad/Rawalpindi | Biotech & Vaccines (NIBGE) | | 4 | Peshawar (Hayatabad) | Export hub to Afghanistan | | 5 | Faisalabad | Veterinary drugs | Download the PDF version of this Pakistan Pharma Guide for offline reference. [Link to PDF] pakistan pharma guide

By [Author Name] Published: [Date] Introduction: An Industry at the Crossroads In the labyrinth of Pakistan’s economy, one sector stands resilient yet strained: Pharmaceuticals . Worth over $3.5 billion and growing at a compound annual rate of approximately 10-12%, the Pakistani pharma industry is the 8th largest manufacturer of Active Pharmaceutical Ingredients (APIs) in Asia and a critical lifeline for over 220 million people. Over 700 registered pharma companies operate in Pakistan

Welcome to the —your deep dive into the machinery, the medicine, and the malpractice of an industry that touches every home, yet remains largely misunderstood. Chapter 1: The Giants & The Garage Startups (Market Structure) The landscape of Pakistan’s pharma is a tale of two extremes. At the top sit the multinationals (MNCs) like GlaxoSmithKline (GSK) , Pfizer , Sanofi-Aventis , and Bayer . These players dominate the high-end, patented medicine sector, operating with stringent GMP (Good Manufacturing Practices) and deep R&D pockets. Chapter 2: The Price War (Drug Pricing &

But behind the blister packs and IV drips lies a complex ecosystem of regulatory hurdles, price controls, export ambitions, and a silent epidemic of counterfeit drugs.

Alongside them are the local heavyweights: , Getz Pharma , Ferozsons , Highnoon , and Martin Dow . Notably, Getz Pharma has broken the local ceiling by becoming a regional exporter, proving that Pakistani formulations can compete globally.